Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Informed Consent Process

Posted on By

Guidelines for Participant Consent in BA/BE Studies

Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for obtaining informed consent from participants in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry.

Scope

This SOP applies to all personnel involved in the recruitment, enrollment, and consent process of study participants, including Principal Investigators, Study Coordinators, and Clinical Research Associates.

Responsibilities

  • The Principal Investigator (PI) or Study Coordinator is responsible for ensuring that informed consent is obtained from all study participants.
  • The Regulatory Affairs team is responsible for ensuring that the informed consent process complies with regulatory requirements and guidelines.
  • Study personnel involved in obtaining informed consent must be adequately trained and competent in explaining study details and answering participant questions.
See also  SOP for Final Report Preparation

Procedure

  1. Provide participants with comprehensive information about the study purpose, procedures, risks, benefits, and alternatives in a language and format they understand.
  2. Ensure that participants have adequate time to review the informed consent document and ask questions before signing.
  3. Address any participant concerns or questions in a clear and understandable manner, documenting all discussions and clarifications.
  4. Obtain written informed consent from participants or their legally authorized representatives before initiating any study-related procedures.
  5. Ensure that participants are informed of their right to withdraw from the study at any time without penalty and how their data will be handled in such cases.
  6. Provide participants with a copy of the signed informed consent document for their records.
  7. Maintain accurate and up-to-date records of informed consent documentation in the study master file.
See also  SOP for Conflict of Interest Disclosure

Abbreviations

  • SOP – Standard Operating Procedure
  • BA – Bioavailability
  • BE – Bioequivalence
  • PI – Principal Investigator

Documents

  • Informed Consent Form
  • Participant Information Sheet
  • Record of Informed Consent Discussions
  • Consent Documentation Log

Reference

International Conference on Harmonisation (ICH) E6 Good Clinical Practice guidelines.

SOP Version

Version 1.0

Bioequivalence Bioavailability Study Tags:AUC (area under the curve), BE assessment, Bioavailability study, Bioequivalence study, clinical trials, Cmax (maximum concentration), Comparative pharmacokinetics, Drug absorption, Drug absorption rate, Drug bioanalysis, Drug development, Drug dissolution, Drug formulation, Drug metabolism, In vitro bioequivalence, In vivo bioavailability, Pharmacokinetic parameters, Pharmacokinetics, SOP for Bioavailability study, SOP for Bioequivalence study, Therapeutic equivalence, Tmax (time to maximum concentration)

Post navigation

Previous Post: SOP for Ethical Approval of Studies
Next Post: SOP for Subject Recruitment and Selection

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version